On the one hand, in patients with RA, the signaling pathway for chemokines (CCL4/CCR5/c-Jun and c-Fos/CCL2) was involved in the expression of CCL2, which could lead to the chronic inflammation associated with RA [34]. This evidence concerns the gene JUN and rheumatoid arthritis.